Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Completed 3Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 6INDUSTRY 5

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Dermatologic 6

Conditions

Carcinoma, Basal Cell 6Skin Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms, Basal Cell 2Neoplasm Metastasis 2Multiple Myeloma 2Lung Neoplasms 2Carcinoma, Hepatocellular 2Carcinoma 2Basal Cell Nevus Syndrome 2Thrombocythemia, Essential 1Squamous Cell Carcinoma of Head and Neck 1Rhabdoid Tumor 1Recurrence 1Pyloric Stenosis, Hypertrophic 1Primary Myelofibrosis 1Polycythemia Vera 1Pinealoma 1Pancreatic Ductal Adenocarcinoma 1Pancreatic Diseases 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Neuroepithelial 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Microphthalmia, Isolated, with Coloboma 5 1

Interventions

HhAntag691 14Biopsy 8Imiquimod 7Aminolevulinic Acid 7sonidegib 6Tomography, Optical Coherence 6Surgical Procedures, Operative 6Photochemotherapy 6Mohs Surgery 61-phenyl-3,3-dimethyltriazene 6Radiotherapy 5Itraconazole 5Nivolumab 4Microscopy, Confocal 4Curettage 4pembrolizumab 3methyl 5-aminolevulinate 3cemiplimab 3Standard of Care 3Niacinamide 3tazarotene 2relatlimab 2X-Rays 2Watchful Waiting 2Specimen Handling 2Observation 2Magnetic Resonance Spectroscopy 2Laser Therapy 2Gene Expression Profiling 2Eflornithine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Basal Cell × sonidegib × Clear all
NCT03534947 2025-12-16

SONIB

Melanoma Institute Australia

Phase 2 Completed
16 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

NCT07068568 2025-07-16

BCC-Sonidegib

Federico II University

Completed
12 enrolled
Dermatologic

Carcinoma, Basal Cell, Eyelid Neoplasms, Neoplasms, Basal Cell

NCT05463757 2025-04-04

Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study

Maastricht University Medical Center

Recruiting
80 enrolled
Dermatologic

Basal Cell Nevus Syndrome, Carcinoma, Carcinoma, Basal Cell, Skin Neoplasms, Neoplasms, Basal Cell

NCT04679480 2024-07-30

Anti-PD1-antibody and Pulsed HHI for Advanced BCC

University of Zurich

Phase 2 Active not recruiting
20 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT02303041 2019-01-29

Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma

Stanford University

Phase 2 Terminated
10 enrolled 11 charts
Dermatologic

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell, Skin Neoplasms

NCT01529450 2017-01-16

Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors

Stanford University

Phase NA Completed
11 enrolled 10 charts
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡